New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

42

AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd

AstraZeneca’s Covid-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on July 28, after worries over side effects.

45

Biogen Props Up Aduhelm’s Controversial Win with New Data at Alzheimer’s Conference

One of the eagerly anticipated presentations at the 2021 Alzheimer’s Association International Conference in Denver and virtually is Biogen and the company’s partner Eisai on their controversial drug Aduhelm (aducanumab). Biogen is also presenting new data on a different Alzheimer’s drug with another partner, Ionis Pharmaceuticals.